🔗 Visit the ClinicalTrials.gov page for NCT00941070
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Iron and cancer: more ore to be mined. | Nat Rev Cancer | 2013 | 2.40 |
| 2 | Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. | Gynecol Oncol | 2013 | 1.02 |
| 3 | A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. | Cancer Chemother Pharmacol | 2011 | 0.84 |
| 4 | Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer. | Front Oncol | 2014 | 0.81 |